MLC Dx

Companies developing DNA sequencing and related technologies, as well as firms working on sequencing-based genetic tests, were among almost 3,000 small biotechs who received a total of $1 billion in grants and tax credits under the QTDP program.

People in the News

Premium

Norrie Russell, Thomas Willis, Malek Faham

Company executives have a patent pending that describes methods “for using DNA sequencing to identify personalized biomarkers in patients with autoimmune disease and other conditions,” according to the recently published patent application.

Paired Ends

Premium

Thomas Willis, Malek Faham, Lawrence Tabak

The molecular diagnostics firm currently has a patent application for a method of using DNA sequencing technology for identifying biomarkers of autoimmune disease.

Researchers at Affymetrix, Genentech, and Stanford University's Genome Technology Center have created a new array-based resequencing assay that they claim is scalable enough to compete with second-generation sequencing platforms.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.